Table 1—

Serum lipids, insulin sensitivity, and circulating adiponectin in subjects with fatty liver and in control subjects, as well as correlations of these characteristics with liver fat as a continuous variable

Fatty liver (n = 16)Control subjects (n = 24)PP*Liver fat
rPr*P*
Triglyceride (mg/dl)171 ± 2992 ± 80.0030.210.470.0020.220.18
Cholesterol (mg/dl)
    Total194 ± 9179 ± 60.160.660.180.250.0050.98
    LDL127 ± 8111 ± 50.090.760.260.110.030.86
    HDL45 ± 255 ± 30.020.22−0.440.005−0.310.06
    HDL24.7 ± 0.48.5 ± 0.90.00080.049−0.540.0003−0.370.02
    HDL322.2 ± 1.022.7 ± 0.90.700.23−0.120.460.110.51
    HDL2-to-HDL30.21 ± 0.010.37 ± 0.030.00010.004−0.58<0.0001−0.480.002
ApoAI (mg/dl)139 ± 4150 ± 50.120.28−0.280.08−0.230.17
ApoB (mg/dl)102 ± 585 ± 30.0090.490.410.0090.110.51
Insulin sensitivity (AU)7.5 ± 0.919.1 ± 1.4<0.0001−0.77<0.0001
Adiponectin (μg/ml)9.3 ± 0.714.2 ± 1.00.00020.28−0.480.002−0.030.84
  • Data are means ± SD.

  • *

    * Additionally adjusted for insulin sensitivity. AU, arbitrary units.